BECN1 and diabetes mellitus: Metformin is used in diabetes mellitus; it is thought to trigger AMPK upstream of the Becn1/Ulk1/Vps34 complex [38], though it has additional metabolic effects [39] that may impact stem cells [40] and contribute to its documented capacity to improve survival of ovarian cancer patients [41].